An in vivo study (42) on trans-retinoic acid and colon cancer found decreased ALDH1A1 and ALDH1A3 protein expression, while ALDH1A2 protein expression remained unchanged in colon cancer progression with alterations in the gut microbiome. The gene discussed is ALDH1A3; the disease is colonic neoplasm.